Vaccine Research and Development Center
DEJIMA Infectious Disease Research Alliance
Nagasaki University

Contact
  • Vaccine development research newly started in Nagasaki,
    the birthplace of vaccines in Japan.
Topics
View all
About us
Vaccine Research and Development Center (VRDC), DEJIMA Infectious Disease Research Alliance (DIDA), Nagasaki University is one of the four synergistic centers selected for the Project 'Japan Initiative for World-leading Vaccine Research and Development Centers'. It aims to promote the development of vaccines against highly pathogenic and tropical pathogens that have been studied by Nagasaki University and to develop vaccines against infectious diseases that pose a threat to mankind.
Careers

  • There is no registered post.

Publications
12924226 1 apa 5 default desc year 1 115 https://dida.nagasaki-u.ac.jp/dida_wp/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22FBLSNY32%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kubo%20et%20al.%22%2C%22parsedDate%22%3A%222025-09-30%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKubo%2C%20R.%2C%20Yoshikawa%2C%20R.%2C%20Fujii%2C%20Y.%2C%20Kawasaki%2C%20T.%2C%20Takazono%2C%20T.%2C%20Izumikawa%2C%20K.%2C%20Ariyoshi%2C%20K.%2C%20Mukae%2C%20H.%2C%20%26amp%3B%20Yasuda%2C%20J.%20%282025%29.%20Sustained%20humoral%20immunity%20in%20the%20patients%20recovered%20from%20severe%20fever%20with%20thrombocytopenia%20syndrome.%20%26lt%3Bi%26gt%3BTropical%20Medicine%20and%20Health%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B53%26lt%3B%5C%2Fi%26gt%3B%281%29%2C%20127.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs41182-025-00807-4%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs41182-025-00807-4%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Sustained%20humoral%20immunity%20in%20the%20patients%20recovered%20from%20severe%20fever%20with%20thrombocytopenia%20syndrome%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ryotaro%22%2C%22lastName%22%3A%22Kubo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rokusuke%22%2C%22lastName%22%3A%22Yoshikawa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuji%22%2C%22lastName%22%3A%22Fujii%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Takumi%22%2C%22lastName%22%3A%22Kawasaki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Takahiro%22%2C%22lastName%22%3A%22Takazono%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Koichi%22%2C%22lastName%22%3A%22Izumikawa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Koya%22%2C%22lastName%22%3A%22Ariyoshi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hiroshi%22%2C%22lastName%22%3A%22Mukae%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jiro%22%2C%22lastName%22%3A%22Yasuda%22%7D%5D%2C%22abstractNote%22%3A%22Abstract%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Background%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Severe%20fever%20with%20thrombocytopenia%20syndrome%20%28SFTS%29%20is%20a%20tick-borne%20viral%20disease%20with%20a%20mortality%20rate%20of%2010%5Cu201330%25%3B%20however%2C%20effective%20vaccines%20and%20therapies%20for%20this%20disease%20have%20not%20yet%20been%20developed.%20Understanding%20the%20long-term%20immune%20response%20of%20recovered%20individuals%20is%20critical%20for%20vaccine%20development%20and%20treatment.%20In%20this%20study%2C%20we%20conducted%20an%20epidemiological%20investigation%20of%20antibody%20and%20memory%20B%20cell%20trends%20in%20individuals%20with%20SFTS.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Methods%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Peripheral%20blood%20mononuclear%20cells%20%28PBMCs%29%20and%20plasma%20were%20collected%20from%2016%20survivors%20of%20SFTS%20and%20five%20healthy%20controls.%20SFTS%20virus%20%28SFTSV%29-specific%20humoral%20immune%20responses%20were%20assessed%20using%20enzyme-linked%20immunosorbent%20assay%20%28ELISA%29%2C%20biolayer%20interferometry%20%28BLI%29%2C%20neutralization%20assays%2C%20and%20flow%20cytometry.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Results%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20SFTSV%20Gn-specific%20IgG%20was%20detected%20in%20plasma%20samples%20from%20all%20patients%20using%20ELISA%20and%20BLI.%20All%20patient%20plasma%20samples%20also%20presented%20neutralizing%20activity%20against%20SFTSV%20infection%2C%20and%20the%20IC%5Cu2085%5Cu2080%20values%20were%20correlated%20with%20ELISA%20OD%20values%20%28%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cu03c1%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cu2009%3D%5Cu20090.700%2C%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20P%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cu2009%3D%5Cu20090.003%20and%20BLI%20signals%20%28%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cu03c1%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cu2009%3D%5Cu20090.818%2C%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20P%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cu2009%3D%5Cu20090.0002%29.%20Neutralizing%20antibodies%20and%20SFTSV%20Gn-specific%20memory%20B%20cells%20were%20detected%20in%20samples%20from%20patients%20up%20to%206.7%5Cu00a0years%20post-infection.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Conclusion%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20SFTSV-specific%20humoral%20immunity%2C%20including%20neutralizing%20antibodies%20and%20memory%20B%20cells%2C%20can%20persist%20in%20the%20majority%20of%20recovered%20patients%2C%20including%20those%20as%20late%20as%206.7%5Cu00a0years%20post-infection.%20This%20information%20will%20be%20useful%20for%20the%20development%20of%20vaccines%20and%20antiviral%20therapies%20using%20antibodies%20against%20SFTS.%22%2C%22date%22%3A%222025-09-30%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1186%5C%2Fs41182-025-00807-4%22%2C%22ISSN%22%3A%221349-4147%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Ftropmedhealth.biomedcentral.com%5C%2Farticles%5C%2F10.1186%5C%2Fs41182-025-00807-4%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-12-08T04%3A31%3A11Z%22%7D%7D%2C%7B%22key%22%3A%22J7BP34AK%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Yoshikawa%20et%20al.%22%2C%22parsedDate%22%3A%222025-11-04%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BYoshikawa%2C%20R.%2C%20Sakurai%2C%20Y.%2C%20Kondo%2C%20S.%2C%20Kimura%2C%20M.%2C%20%26amp%3B%20Yasuda%2C%20J.%20%282025%29.%20Crimean-Congo%20hemorrhagic%20fever%20virus%20NSm%20protein%20inhibits%20the%20type%20I%20interferon%20signaling%20by%20binding%20to%20STAT2.%20%26lt%3Bi%26gt%3BPLOS%20Neglected%20Tropical%20Diseases%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B19%26lt%3B%5C%2Fi%26gt%3B%2811%29%2C%20e0013695.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pntd.0013695%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pntd.0013695%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Crimean-Congo%20hemorrhagic%20fever%20virus%20NSm%20protein%20inhibits%20the%20type%20I%20interferon%20signaling%20by%20binding%20to%20STAT2%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rokusuke%22%2C%22lastName%22%3A%22Yoshikawa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yasuteru%22%2C%22lastName%22%3A%22Sakurai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sayako%22%2C%22lastName%22%3A%22Kondo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mayuko%22%2C%22lastName%22%3A%22Kimura%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jiro%22%2C%22lastName%22%3A%22Yasuda%22%7D%2C%7B%22creatorType%22%3A%22editor%22%2C%22firstName%22%3A%22Roger%22%2C%22lastName%22%3A%22Hewson%22%7D%5D%2C%22abstractNote%22%3A%22The%20type%20I%20interferon%20%28IFN-I%29%20response%2C%20which%20includes%20IFN-I%20induction%20and%20signaling%2C%20plays%20an%20important%20role%20in%20a%20host%5Cu2019s%20defence%20against%20viral%20infections.%20Many%20pathogenic%20viruses%20target%20it%20to%20evade%20the%20host%20immunity.%20Crimean-Congo%20hemorrhagic%20fever%20virus%20%28CCHFV%29%2C%20the%20causative%20agent%20of%20Crimean-Congo%20hemorrhagic%20fever%2C%20which%20features%20high%20mortality%20in%20humans%2C%20has%20been%20reported%20in%20southeastern%20Europe%2C%20Africa%2C%20the%20Middle%20East%2C%20and%20Asia.%20Although%20a%20previous%20study%20reported%20that%20CCHFV%20antagonizes%20IFN-I%20signaling%20in%20human%20cell%20lines%2C%20it%20is%20unclear%20how%20it%20inhibits%20IFN-I%20signaling.%20Here%20we%20demonstrated%20that%20the%20non-structural%20protein%20of%20CCHFV%2C%20NSm%2C%20suppresses%20IFN-I%20signaling%20in%20human%20cell%20lines.%20Furthermore%2C%20we%20discovered%20that%20NSm%20binds%20to%20STAT2%2C%20an%20important%20host%20protein%20in%20IFN-I%20signaling%2C%20and%20induces%20its%20degradation%20within%20cells.%20Taken%20together%2C%20our%20results%20imply%20that%20NSm%20suppresses%20IFN-I%20signaling%20by%20targeting%20human%20STAT2.%22%2C%22date%22%3A%222025-11-4%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pntd.0013695%22%2C%22ISSN%22%3A%221935-2735%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdx.plos.org%5C%2F10.1371%5C%2Fjournal.pntd.0013695%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-12-08T04%3A30%3A44Z%22%7D%7D%2C%7B%22key%22%3A%22Y2NGN46F%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Raekiansyah%20et%20al.%22%2C%22parsedDate%22%3A%222025-08-18%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BRaekiansyah%2C%20M.%2C%20Rahmasari%2C%20R.%2C%20Baihaqy%2C%20F.%2C%20Irhamsyah%2C%20M.%2C%20Fajriani%2C%20N.%20I.%2C%20Putri%2C%20M.%20M.%2C%20Maharani%2C%20B.%2C%20Sauriasari%2C%20R.%2C%20Urano%2C%20T.%2C%20Ngwe%20Tun%2C%20M.%20M.%2C%20%26amp%3B%20Morita%2C%20K.%20%282025%29.%20High%20Concordance%20Between%20SYBR%20Green%20and%20TaqMan%20PCR%20for%20SARS-CoV-2%20Detection%20in%20Nasopharyngeal%20and%20Saliva%20Samples.%20%26lt%3Bi%26gt%3BViruses%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B17%26lt%3B%5C%2Fi%26gt%3B%288%29%2C%201130.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fv17081130%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fv17081130%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22High%20Concordance%20Between%20SYBR%20Green%20and%20TaqMan%20PCR%20for%20SARS-CoV-2%20Detection%20in%20Nasopharyngeal%20and%20Saliva%20Samples%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muhareva%22%2C%22lastName%22%3A%22Raekiansyah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ratika%22%2C%22lastName%22%3A%22Rahmasari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fathan%22%2C%22lastName%22%3A%22Baihaqy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muhamad%22%2C%22lastName%22%3A%22Irhamsyah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nurul%20Izza%22%2C%22lastName%22%3A%22Fajriani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mila%20Meilani%22%2C%22lastName%22%3A%22Putri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Botefilia%22%2C%22lastName%22%3A%22Maharani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rani%22%2C%22lastName%22%3A%22Sauriasari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Takeshi%22%2C%22lastName%22%3A%22Urano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mya%20Myat%22%2C%22lastName%22%3A%22Ngwe%20Tun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kouichi%22%2C%22lastName%22%3A%22Morita%22%7D%5D%2C%22abstractNote%22%3A%22During%20the%20COVID-19%20pandemic%2C%20the%20standard%20diagnostic%20assay%20for%20SARS-CoV-2%20detection%20was%20RT-qPCR%20using%20TaqMan%20probes%2C%20with%20samples%20primarily%20taken%20through%20nasal%20and%20oropharyngeal%20swabs.%20The%20TaqMan-based%20method%20is%20costly%2C%20highlighting%20the%20need%20for%20a%20more%20affordable%20alternative%20for%20SARS-CoV-2%20diagnosis.%20As%20an%20alternative%20strategy%2C%20we%20developed%20and%20evaluated%20a%20SYBR%20Green-based%20RT-qPCR%20method%20targeting%20the%20RNA-dependent%20RNA%20polymerase%20%28RdRp%29%20gene%20of%20SARS-CoV-2.%20Under%20optimized%20RT-qPCR%20conditions%2C%20the%20sensitivity%20and%20linearity%20of%20the%20SYBR%20assays%20were%20assessed%20by%20using%20in%20vitro-transcribed%20RNA%20and%20RNA%20extracted%20from%20cultured%20SARS-CoV-2%20isolates%20of%20the%20Wuhan%20reference%20strain%20and%20various%20circulating%20variants.%20Our%20results%20demonstrated%20that%20the%20SYBR%20Green-based%20RT-qPCR%20method%20was%20successfully%20developed%20with%20sufficient%20performance.%20The%20assay%20could%20detect%20up%20to%2025%20copies%20of%20in%20vitro-transcript%20RNA%20per%20reaction.%20Meanwhile%2C%20using%20the%20RNA%20extracted%20from%20cultured%20virus%2C%20the%20SYBR%20green%20assay%20was%20able%20to%20detect%20virus%20concentrations%20at%20least%20as%20low%20as%201%20PFU%5C%2FmL%20per%20reaction%20for%20all%20the%20variants%20tested.%20When%20tested%20on%20clinically%20relevant%20samples%20%2888%20naso-oropharyngeal%20swabs%20and%2047%20saliva%20samples%29%2C%20comparable%20results%20with%20the%20TaqMan%20assay%20were%20demonstrated.%20The%20Ct%20values%20of%20both%20methods%20for%20the%20positively%20detected%20samples%20were%20similar%2C%20with%20a%20difference%20in%20Ct%20of%200.72%20%5Cu00b1%200.83%20%28p%20%3D%200.392%29%20and%20%5Cu22120.7765%20%5Cu00b1%200.6107%20%28p%20%3D%200.209%29%20for%20naso-oropharyngeal%20swab%20and%20saliva%20samples%2C%20respectively.%20These%20findings%20suggest%20that%20the%20SYBR%20method%20is%20reliable%20and%20thus%20offers%20an%20alternative%20assay%20for%20the%20detection%20of%20SARS-CoV-2.%20In%20particular%2C%20using%20saliva%20specimens%20could%20allow%20this%20assay%20to%20serve%20as%20a%20simple%20approach%20for%20SARS-CoV-2%20detection.%22%2C%22date%22%3A%222025-08-18%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.3390%5C%2Fv17081130%22%2C%22ISSN%22%3A%221999-4915%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.mdpi.com%5C%2F1999-4915%5C%2F17%5C%2F8%5C%2F1130%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-12-03T06%3A44%3A49Z%22%7D%7D%2C%7B%22key%22%3A%22M9CSH56J%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Raekiansyah%20et%20al.%22%2C%22parsedDate%22%3A%222025-08-19%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BRaekiansyah%2C%20M.%2C%20Ngwe%20Tun%2C%20M.%20M.%2C%20Ang%2C%20A.%2C%20Lee%2C%20A.%2C%20Macalino%2C%20S.%20J.%2C%20Billones%2C%20J.%2C%20Takamatsu%2C%20Y.%2C%20Urano%2C%20T.%2C%20Murao%2C%20L.%20A.%20E.%2C%20Quiming%2C%20N.%2C%20Morita%2C%20K.%2C%20%26amp%3B%20Carrillo%2C%20M.%20C.%20%282025%29.%20Antiviral%20Activity%20of%20Medicinal%20Plant%20Extracts%20Vitex%20negundo%20and%20Macaranga%20tanarius%20Against%20SARS-CoV-2.%20%26lt%3Bi%26gt%3BPathogens%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B14%26lt%3B%5C%2Fi%26gt%3B%288%29%2C%20820.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fpathogens14080820%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fpathogens14080820%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Antiviral%20Activity%20of%20Medicinal%20Plant%20Extracts%20Vitex%20negundo%20and%20Macaranga%20tanarius%20Against%20SARS-CoV-2%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muhareva%22%2C%22lastName%22%3A%22Raekiansyah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mya%20Myat%22%2C%22lastName%22%3A%22Ngwe%20Tun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Ang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephani%20Joy%22%2C%22lastName%22%3A%22Macalino%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Junie%22%2C%22lastName%22%3A%22Billones%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuki%22%2C%22lastName%22%3A%22Takamatsu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Takeshi%22%2C%22lastName%22%3A%22Urano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lyre%20Anni%20E.%22%2C%22lastName%22%3A%22Murao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Noel%22%2C%22lastName%22%3A%22Quiming%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kouichi%22%2C%22lastName%22%3A%22Morita%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%20Constancia%22%2C%22lastName%22%3A%22Carrillo%22%7D%5D%2C%22abstractNote%22%3A%22Natural%20products%20possess%20a%20wide%20range%20of%20biological%20and%20biochemical%20potentials%2C%20with%20plant-derived%20compounds%20being%20significant%20sources%20for%20discovering%20new%20drugs.%20In%20this%20study%2C%20extracts%20of%20Vitex%20negundo%20and%20Macaranga%20tanarius%20prepared%20with%20different%20solvents%20were%20tested%20for%20their%20antiviral%20activity%20against%20the%20original%20SARS-CoV-2%20Wuhan%20strain%20and%20its%20variants%20using%20plaque%20assay%2C%20quantitative%20real%20time%20RT-PCR%2C%20and%20immunofluorescence%20assay%20%28IFA%29.%20Our%20results%20showed%20that%20at%20their%20maximum%20non-toxic%20concentrations%2C%20Vitex-Dichloromethane%20%28DCM%29%20and%20Macaranga%20extracts%20significantly%20inhibited%20SARS-CoV-2%20Wuhan%20strain%20growth%20in%20Vero%20E6%20cells%2C%20showing%20a%205-log%20reduction%20in%20plaque%20assay%20and%20confirmed%20by%20IFA.%20Meanwhile%2C%20Vitex-Hexane%20showed%20moderate%20activity%20with%20a%202-log%20decrease.%20The%20inhibition%20was%20shown%20in%20a%20dose-dependent%20manner.%20The%20antiviral%20efficacy%20of%20these%20extracts%20was%20further%20demonstrated%20against%20various%20SARS-CoV-2%20variants%20including%20Alpha%2C%20Beta%2C%20Delta%2C%20and%20Omicron.%20Both%20Vitex-DCM%20and%20Macaranga%20showed%20strong%20virucidal%20activity.%20In%20addition%2C%20Vitex-DCM%20and%20Macaranga%20inhibited%20the%20transcriptional%20activity%20of%20purified%20SARS-CoV-2%20RdRp%2C%20indicating%20that%20RdRp%20inhibition%20may%20contribute%20to%20viral%20suppression%20as%20shown%20at%20the%20post-infection%20stage.%20Furthermore%2C%20combining%20Vitex-DCM%20or%20Macaranga%20with%20remdesivir%20showed%20a%20synergistic%20effect%20against%20SARS-CoV-2.%20These%20results%20suggest%20that%20Vitex%20negundo%20and%20Macaranga%20tanarius%20extracts%20are%20promising%20candidates%20for%20anti-SARS-CoV-2%20treatments.%20Their%20synergy%20with%20remdesivir%20also%20underscores%20the%20potential%20of%20drug%20combinations%20in%20fighting%20SARS-CoV-2%20and%20preventing%20the%20emergence%20of%20mutant%20variants.%22%2C%22date%22%3A%222025-08-19%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.3390%5C%2Fpathogens14080820%22%2C%22ISSN%22%3A%222076-0817%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.mdpi.com%5C%2F2076-0817%5C%2F14%5C%2F8%5C%2F820%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-12-03T06%3A44%3A15Z%22%7D%7D%2C%7B%22key%22%3A%22G3PU63BC%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ngwe%20Tun%20et%20al.%22%2C%22parsedDate%22%3A%222025-10-09%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BNgwe%20Tun%2C%20M.%20M.%2C%20Nwe%2C%20K.%20M.%2C%20John%2C%20J.%20L.%2C%20Mumo%2C%20M.%2C%20Manah%2C%20A.%20M.%2C%20Takamatsu%2C%20Y.%2C%20Urano%2C%20T.%2C%20Morita%2C%20K.%2C%20%26amp%3B%20Ahmed%2C%20K.%20%282025%29.%20Molecular%20and%20Serological%20Detection%20of%20Zika%20Virus%20and%20Zika%26%23x2013%3BDengue%20Virus%20Coinfections%20in%20Febrile%20Patients%20in%20Sabah%2C%20Malaysia%2C%202019%26%23x2013%3B2020.%20%26lt%3Bi%26gt%3BThe%20American%20Journal%20of%20Tropical%20Medicine%20and%20Hygiene%26lt%3B%5C%2Fi%26gt%3B%2C%20tpmd250066.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.4269%5C%2Fajtmh.25-0066%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.4269%5C%2Fajtmh.25-0066%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Molecular%20and%20Serological%20Detection%20of%20Zika%20Virus%20and%20Zika%5Cu2013Dengue%20Virus%20Coinfections%20in%20Febrile%20Patients%20in%20Sabah%2C%20Malaysia%2C%202019%5Cu20132020%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mya%20Myat%22%2C%22lastName%22%3A%22Ngwe%20Tun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Khine%20Mya%22%2C%22lastName%22%3A%22Nwe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jecelyn%20Leaslie%22%2C%22lastName%22%3A%22John%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maurine%22%2C%22lastName%22%3A%22Mumo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abdul%20Marsudi%22%2C%22lastName%22%3A%22Manah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuki%22%2C%22lastName%22%3A%22Takamatsu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Takeshi%22%2C%22lastName%22%3A%22Urano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kouichi%22%2C%22lastName%22%3A%22Morita%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kamruddin%22%2C%22lastName%22%3A%22Ahmed%22%7D%5D%2C%22abstractNote%22%3A%22Zika%20virus%20%28ZIKV%29%20infection%20is%20a%20mosquito-borne%20disease%20produced%20by%20a%20virus%20of%20the%20Flaviviridae%20family.%20It%20can%20either%20be%20asymptomatic%20or%20cause%20mild%20febrile%20illness%20similar%20to%20dengue%20fever.%20This%20study%20collected%20188%20serum%20samples%20from%20acute%20febrile%20patients%20in%20Kota%20Kinabalu%20and%20Lahad%20Datu%2C%20Sabah%2C%20Malaysia.%20The%20ZIKV%20genome%20was%20detected%20in%2013%20%286.9%25%29%20patients%2C%20and%20among%20these%2C%20dengue%20virus%20%28DENV%29%20was%20detected%20by%20quantitative%20reverse%20transcription%20polymerase%20chain%20reaction%20in%206%20%283.2%25%29%20patients.%20Thirty-seven%20patients%20%2819.7%25%29%20tested%20positive%20for%20IgM%20against%20ZIKV%2C%20and%2011%20patients%20%285.9%25%29%20showed%20positive%20neutralization%20against%20ZIKV.%20The%20positive%20rate%20included%207%20%283.7%25%29%20individuals%20with%20coinfection%20of%20ZIKV%5Cu2013DENV%2C%2012%20%286.4%25%29%20individuals%20with%20confirmed%20ZIKV%2C%20and%203%20%281.6%25%29%20individuals%20with%20probable%20ZIKV.%20Our%20study%20concludes%20that%20ZIKV%20infection%20and%20DENV%5Cu2013ZIKV%20coinfection%20were%20detected%20among%20febrile%20patients%20in%20Kota%20Kinabalu%2C%20Sabah%20during%202019%5Cu20132020.%20Therefore%2C%20a%20serosurveillance%20system%20is%20essential%20to%20determine%20the%20circulation%20of%20ZIKV%20in%20this%20area.%22%2C%22date%22%3A%222025-10-09%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.4269%5C%2Fajtmh.25-0066%22%2C%22ISSN%22%3A%220002-9637%2C%201476-1645%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ajtmh.org%5C%2Fview%5C%2Fjournals%5C%2Ftpmd%5C%2Faop%5C%2Farticle-10.4269-ajtmh.25-0066%5C%2Farticle-10.4269-ajtmh.25-0066.xml%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-12-03T06%3A43%3A27Z%22%7D%7D%5D%7D
Kubo, R., Yoshikawa, R., Fujii, Y., Kawasaki, T., Takazono, T., Izumikawa, K., Ariyoshi, K., Mukae, H., & Yasuda, J. (2025). Sustained humoral immunity in the patients recovered from severe fever with thrombocytopenia syndrome. Tropical Medicine and Health, 53(1), 127. https://doi.org/10.1186/s41182-025-00807-4
Yoshikawa, R., Sakurai, Y., Kondo, S., Kimura, M., & Yasuda, J. (2025). Crimean-Congo hemorrhagic fever virus NSm protein inhibits the type I interferon signaling by binding to STAT2. PLOS Neglected Tropical Diseases, 19(11), e0013695. https://doi.org/10.1371/journal.pntd.0013695
Raekiansyah, M., Rahmasari, R., Baihaqy, F., Irhamsyah, M., Fajriani, N. I., Putri, M. M., Maharani, B., Sauriasari, R., Urano, T., Ngwe Tun, M. M., & Morita, K. (2025). High Concordance Between SYBR Green and TaqMan PCR for SARS-CoV-2 Detection in Nasopharyngeal and Saliva Samples. Viruses, 17(8), 1130. https://doi.org/10.3390/v17081130
Raekiansyah, M., Ngwe Tun, M. M., Ang, A., Lee, A., Macalino, S. J., Billones, J., Takamatsu, Y., Urano, T., Murao, L. A. E., Quiming, N., Morita, K., & Carrillo, M. C. (2025). Antiviral Activity of Medicinal Plant Extracts Vitex negundo and Macaranga tanarius Against SARS-CoV-2. Pathogens, 14(8), 820. https://doi.org/10.3390/pathogens14080820
Ngwe Tun, M. M., Nwe, K. M., John, J. L., Mumo, M., Manah, A. M., Takamatsu, Y., Urano, T., Morita, K., & Ahmed, K. (2025). Molecular and Serological Detection of Zika Virus and Zika–Dengue Virus Coinfections in Febrile Patients in Sabah, Malaysia, 2019–2020. The American Journal of Tropical Medicine and Hygiene, tpmd250066. https://doi.org/10.4269/ajtmh.25-0066
View all
PAGE TOP
Contact